Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bladder squamous cell carcinoma biomarkers derived from proteomics.

J E Celis1, H Wolf, M Ostergaard

  • 1Department of Medical Biochemistry and Danish Center for Human Genome Research, The University of Aarhus, Denmark. jec@biokemi.au.dk

Electrophoresis
|July 13, 2000
PubMed
Summary

Proteomics can identify bladder cancer subtypes and discover urine biomarkers for patient monitoring. This review details methods for analyzing protein expression in health and disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Oral hairy leukoplakia in human immunodeficiency virus positive patients: clinical and etiopathogenic aspects].

Acta otorrinolaringologica espanola·1992
Same author

Reactivities of HIV-1 gag-derived peptides with antibodies of HIV-1-infected and uninfected humans.

AIDS research and human retroviruses·1992
Same author

Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells.

European journal of immunology·1992
Same author

Localization and identification of T-(Gal beta 1-3GalNAc alpha 1-O-R) and T-like antigens in experimental rat bladder cancer.

The Journal of urology·1992
Same author

Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.

Cancer research·1992
Same author

Determination of placental ferritin (PLF)-positive lymphocytes in women in early stages of breast cancer.

International journal of cancer·1992

Area of Science:

  • Biochemistry
  • Oncology
  • Proteomics

Background:

  • Proteomics enables simultaneous analysis of thousands of proteins in health and disease.
  • Bladder squamous cell carcinoma (SCC) presents diagnostic and monitoring challenges.

Purpose of the Study:

  • To review developed proteomic strategies for identifying metaplastic lesions in bladder SCC.
  • To highlight the use of urine biomarkers for follow-up studies in SCC patients.

Main Methods:

  • Review of established and novel proteomic techniques.
  • Application of proteomic analysis to identify specific protein expression patterns.
  • Validation of identified biomarkers for clinical utility.

Main Results:

Related Experiment Videos

  • Proteomic strategies successfully identified metaplastic lesions in bladder SCC.
  • Key protein biomarkers in urine were identified for SCC patient follow-up.
  • The study provides a framework for utilizing proteomics in bladder cancer research.

    • Conclusions:

    • Proteomics is a powerful tool for understanding bladder SCC.
    • Identified biomarkers can aid in non-invasive patient monitoring.
    • Further research can refine proteomic applications in clinical oncology.